logo

News

February 2024
PRESENTATION AT NACI HPV WORKGROUP MEETING

Marc Brisson presented to the Canadian National Advisory Committee on Immunization (NACI) HPV workgroup meeting on February 8, 2024: “Potential impact of switching from a 2-dose to 1-dose routine HPV vaccination program in Canada”.

January 2024
PRESENTATION AT MIDSEA SEMINAR SERIES

Marc Brisson was invited speaker at the MIDSEA online seminar series on January 17, 2024. He presented ‘Modeling the population-level impact of HPV vaccination to help inform policy decisions’ [ MIDSEA ]

November 2023
PUBLICATION IN THE JOURNAL ‘INFECTIOUS AGENTS AND CANCER’

‘Association of naturally acquired type-specific HPV antibodies and subsequent HPV re-detection: systematic review and meta-analysis’ [ Infect Agents Cancer ]

October 2023
INTERVIEW IN COURRIER LAVAL

Marc Brisson was interviewed by Courrier Laval: ‘Prévenir les cancers du col de l’utérus une dose à la fois’ (Preventing cervical cancers one dose at a time), following our article in The Lancet Public Health.

September 2023
PUBLICATION IN LANCET PUBLIC HEALTH

‘Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis’ [ Lancet PH ]

September 2023
PRESENTATION AT THE NACI HPV WORKGROUP MEETING

Marc Brisson presented to the Canadian National Advisory Committee on Immunization (NACI) HPV workgroup meeting on September 18, 2023: “Potential impact of switching from a 2-dose to 1-dose routine HPV vaccination program in Canada”.

September 2023
PRESENTATION AT THE CIQ MEETING

Marc Brisson participated to the Comité sur l’immunisation du Québec (CIQ) meeting held in Montreal, September 15, 2023. He presented “Potential impact of switching from a 2-dose to 1-dose routine HPV vaccination program in Québec”.

September 2023
PRESENTATION AT WHO IVIR-AC MEETING

Marc Brisson participated to the Immunization and Vaccines Related Implementation Research Advisory Committee (IVIR-AC) of the World Health Organization (WHO) held in Geneva, September 11-15, 2023. He presented “Mathematical modeling of COVID-19 in Burkina Faso and Cameroon”. [ WHO ]

August 2023
PUBLICATION IN BMC MEDICINE

‘Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis’ [ BMC Med ]

May 2023
CIRN GRANT

Marc Brisson was awarded a CIHR Canadian Immunization Research Network (CIRN) Grant: “Optimization of HPV vaccination and screening in Canada, considering opportunities provided by 1-dose vaccination: A mathematical modeling study”.

April 2023
PRESENTATIONS AT IPVC2023

Our team presented at the International Papillomavirus Conference 2023 held in Washington DC, April 17-22, 2023:

  • Jean-François Laprise made an oral presentation on the “Potential impact of switching from a 2-dose to 1-dose routine HPV vaccination program in high-income countries: A mathematical modeling study using North America as an example”.
  • Élodie Bénard made a poster presentation on the “Potential impact of one-dose HPV vaccination in low-and middle-income countries: a modelling analysis”.
March 2023
2023 AWARD FOR HIGH PERFORMANCE COMPUTING RESOURCES

Our proposal received an overall rating (out of 5) of 4.7 in the Digital Research Alliance of Canada 2023 resource allocation competition (Fast track application). Our research group was awarded 399 core-years on Calcul Québec’s Narval supercomputer, which is estimated to an annual contribution of $42,000 from the Alliance.

February 2023
PRESENTATIONS AT EUROGIN 2023
  • Marc Brisson was invited speaker for 2 presentations: the first on “Modelling the impact of HPV vaccination on colposcopy results in highly vaccinated populations” and the second on “Modelling the impact of 1-dose HPV vaccination”.
  • Mélanie Drolet presented on the “Potential impact of one-dose HPV vaccination in low-and-middle-income countries (LMIC): A modeling analysis using HPV-ADVISE LMIC”.
February 2023
PUBLICATION IN PLOS MED

Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000–2020)

January 2023
PUBLICATION IN CLINICAL INFECTIOUS DISEASES

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

December 2022
PUBLICATION IN THE LANCET INFECTIOUS DISEASES

Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study

December 2022
PUBLICATION IN LANCET GLOBAL HEALTH

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis [ Lancet GH ]

December 2022
“DÉCOUVERTES” PRIZES OF THE CHU DE QUÉBEC

Congratulations to the laureates from our team:


• Marc Brisson who was awarded the Ambassadeur étoile (Star Ambassador) Prize for his international outreach and leadership.


• Mélanie Drolet who was awarded the Employée de recherche étoile (Star Research Employee) Prize for her internationally recognized expertise, her exceptional scientific productivity and her positive influence on her teammates.


• The Group of Biostatisticians composed of Myrto Mondor, Caty Blanchette, Éric Demers and Xavier Neveu who was awarded the Groupe collaboratif (Collaborative Group) Prize. This group has provided essential, high quality and constant support in many projects for the past 20 years which has contributed to the success of several CRCHU research groups.

November 2022
PUBLICATION IN E-CLINICAL-MEDICINE

Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening [ eClinicalMedicine ]

October 2022
PUBLICATION IN E-CLINICAL-MEDICINE

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

October 2022
PUBLICATION IN JAMA

Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada. [ JAMA Network ]

September 2022
CONGRATS TO ANDRÉE-ANNE!

Andrée-Anne Sabourin was awarded a Desjardins Training Grant for Research and Innovation for the 2022 competition.

September 2022
CONGRATS TO SABRINA VILLENEUVE!

Sabrina has been riding competitively for several years. She finished 2nd in Quebec and 8th in Canada for the 2022 season in the owner-amateur hunting division, which qualifies her for the Canadian final in Toronto in November 2022. Good luck Sabrina!

August 2022
PUBLICATION OF A LETTER TO THE EDITOR IN VACCINE

Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions [ Vaccine ]

August 2022
PUBLICATION IN VACCINE

Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs

August 2022
JCVI RECOMMENDATIONS

Our team’s work was part of the evidence base that informed the UK Joint Committee on Vaccination and Immunisation (JCVI) statement on a one-dose schedule for the routine HPV immunisation programme in the UK published August 5, 2022 [ JCVI ]

June 2022
PUBLICATION OF A STUDY IN COLLABORATION WITH THE INSPQ

Comparison of the severity of hospitalizations with a diagnosis of COVID-19 during the 4th and 5th waves: Results of June 14, 2022 (French) [ INSPQ ]

June 2022
CONGRATULATIONS TO MÉLANIE DROLET

Mélanie was awarded the ‘2nd prize of the Research Professionals Excellence Awards 2022’ [ FRSQ ]

June 2022
SINGLE DOSE HPV VACCINE EVALUATION CONSORTIUM PUBLICATION

Publication of the ‘Review of the current published evidence on single-dose HPV vaccination 4th Edition’ [ pdf ]

June 2022
AWARDS – 8ÈME JOURNÉE DE LA RECHERCHE DES ÉTUDIANTS DE L’AXE SP-POS

Congratulations to Élodie Bénard who received the 3rd prize for the best oral presentations by doctoral students and to Aurélie Godbout who received the Student Involvement Recognition Award.

May 2022
PUBLICATION IN BMC MEDICINE

Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic

May 2022
PUBLICATION IN BMC PUBLIC HEALTH

Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study

May 2022
PUBLICATION IN INTERNATIONAL JOURNAL OF CANCER

Now or later: Health impacts of delaying single-dose HPV vaccine implementation in a high-burden setting

May 2022
PUBLICATION IN INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Mortality trends and length of stays among hospitalized patients with COVID-19 in Ontario and Québec (Canada): a population-based cohort study of the first three epidemic waves

May 2022
PUBLICATION IN VACCINE

Population immunity to measles in Canada using Canadian Health Measures survey data – A Canadian Immunization Research Network (CIRN) study

May 2022
PUBLICATION OF THE PRELIMINARY RESULTS OF A STUDY IN COLLABORATION WITH THE INSPQ

Protection against Omicron variant conferred by prior COVID-19 (French)

April 2022
PUBLICATION IN CLIN INFECT DIS

Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada

March 2022
PUBLICATION OF THE RESULTS OF A STUDY WITH THE INSPQ

Comparaison des durées de séjour hospitalier selon le variant présomptif

February 2022
PUBLICATION OF THE PRELIMINARY RESULTS OF A STUDY WITH THE INSPQ

Efficacité du vaccin contre la COVID-19 causée par le variant Omicron au Québec : Résultats préliminaires (Efficacy of the vaccine against the COVID-19 caused by the Omicron variant in Quebec: Preliminary results) [ INSPQ ]

October 2021
PREPRINT ARTICLE ON MEDRXIV

‘Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study’ [ medRxiv ]

July 2021
PUBLICATION IN LANCET INFECTIOUS DISEASE

‘Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis’ [ ScienceDirect ]

June 2021
CONGRATULATIONS TO AURÉLIE GODBOUT

Aurélie was awarded 2 prizes for her presentation at the 7th SP-POS Axis Research Day 2021: 1) the 2nd prize for the best oral presentation of master’s students (jury prize) and 2) the public’s favorite award (public vote). His presentation was titled: ‘Les contacts sociaux des québécois avec comorbidités ont-ils pu influencer la sévérité de la 2e vague de COVID-19 ?‘ (Could the social contacts of Quebecers with comorbidities have influenced the severity of the 2nd wave of COVID-19?).

June 2021
PUBLICATION IN VACCINE

‘Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019’ [ PubMed ]

May 2021
PUBLICATION IN PREVENTIVE MEDICINE

From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness [ PubMed ]

May 2021
INTERVIEW FOR ULAVAL NOUVELLES

Aurélie Godbout was interviewed on her master’s work by ULaval nouvelles: ‘COVID-19: la deuxième vague moins sévère en raison des efforts soutenus des personnes à risque?’ [ ULaval nouvelles ]

March 2021
PUBLICATION IN SEXUALLY TRANSMITTED DISEASE

‘The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018’ [ Sex Transm Dis ]

March 2021
INTERVIEW AT 24/60 NEWS TV SHOW

Marc Brisson was interviewed on the 24/60 show hosted by Anne-Marie Dussault on Radio-Canada to explain the results of our modeling of the potential impact of a more transmissible COVID-19 variant in Quebec

February 2021
PUBLICATION IN SEXUALLY TRANSMITTED DISEASES

‘Estimated prevalence and incidence of disease-associated HPV types among 15-59-year-olds in the United States’ [ Sexually Transmitted Diseases ]

February 2021
PUBLICATION IN INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

‘The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada – A mathematical modeling study of surveillance data’ [ Int J Inf Dis ]

January 2021
PUBLICATION IN THE LANCET

‘Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study’ [ THE LANCET ]

January 2021
PUBLICATION IN SEXUALLY TRANSMITTED DISEASE

‘The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018’ [ Sexually Transmitted Diseases ]

January 2021
RADIO-CANADA’S SCIENTIST OF THE YEAR 2020

Marc Brisson, with his team, was chosen as Radio-Canada’s Scientist of the Year 2020 along with 3 other winners to represent mathematical modeling during the COVID-19 pandemic. The award winners were presented on January 17, 2020 on the “Années Lumière” [ Ici Première ] and Découverte [ Ici Radio-Canada ] shows. [ Radio-Canada Info ]

January 2021
PUBLICATION IN VACCINE

‘Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule’ [ Vaccine ]

January 2021
PUBLICATION IN LANCET INFECTIOUS DISEASE

‘Epidemiology of varicella among immigrants and non-immigrants in Quebec, Canada, before and after the introduction of childhood varicella vaccination: a retrospective cohort study’ [ Lancet ID ]

December 2020
CONNECT 4 STUDY

Study on social contacts of Quebecers [ Dynamic vizualisation of results ]

November 2020
REPORT ON RADIO-CANADA’S DÉCOUVERTE SHOW

Radio-Canada’s Découverte show presented a report on our work on modeling COVID-19 in Quebec entitled: ‘Freiner la seconde vague’ [ Ici Radio-Canada ]

July 2020
INTERVIEW IN QUÉBEC SCIENCE

Marc Brisson is interviewed in Québec Science: ‘Faut-il craindre les vacanciers du Grand Montréal?’ [ Québec Science ]

May 2020
REPORT ON RADIO-CANADA’S DÉCOUVERTE SHOW

Radio-Canada’s Découverte show presented a report on our work on modeling COVID-19 in Quebec entitled: ‘La science des contacts’ Ici Radio-Canada ]

April 2020
INTERVIEW AT ‘RADIO-CANADA ICI PREMIÈRE’

Marc Brisson is interviewed by Claude Bernatchez about his work to model the Covid-19 in ‘Le déconfinement, un défi pour la santé publique. Entrevue avec Marc Brisson’. ici première ]

April 2020
INTERVIEW IN ‘LE DEVOIR’

Marc Brisson is interviewed about his work to model the Covid-19 epidemic and the control measures in the province of Quebec in ‘Voir par-delà le sommet de la courbe’. ledevoir ]

April 2020
INTERVIEW IN QUEBEC SCIENCE

Marc Brisson is interviewed about estimating the basic reproduction number (R0, R-naught) of Covid-19 in ‘La quête du véritable R0’. Quebec Science ]

March 2020
COVID-19 – PUBLICATION IN QUEBEC’S LE SOLEIL NEWSPAPER

Covid-19 : voici pourquoi les mesures d’éloignement social sont nécessaires’ LeSoleil ]

March 2020
PUBLICATION OF A POPULAR SCIENCE ARTICLE IN ‘THE CONVERSATION’

Covid-19 : voici pourquoi les mesures d’éloignement social sont nécessaires

February 2020
WIDESPREAD MEDIA COVERAGE

WIDESPREAD MEDIA COVERAGE for our articles published in The Lancet [ Media ] Media tracking via Altmetric ]

February 2020
ASCO’S REPORTS

Our recent meta-analysis published in The Lancet has been selected for inclusion in the Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer. ASCO ]

January 2020
LANCET PUBLICATIONS

Marc Brisson is co-first author on two publications in The Lancet:

  • Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries [ Lancet ]
  • Mortality reductions and lives saved on the path to eliminating cervical cancer in 78 Low and Lower-Middle Income Countries: Comparative modelling of impact of achieving WHO targets for scaling up vaccination, cervical screening and cancer treatment services [ Lancet ]
December 2019

Our recent meta-analysis published in The Lancet ranked in the top 100 by Altmetric out of 2.7 million research outputs in 2019 Altmetric ]

December 2019

PUBLICATION IN ANNALS OF INTERNAL MEDICINE! ‘Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States’ Ann Intern Med ]

November 2019

PUBLICATION IN PAPILLOMAVIRUS RESEARCH: ‘HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control’ Papillomavirus Research ]

October 2019

LAVAL UNIVERSITY COMMUNITY REPORT. Marc Brisson’s research highlighted in Laval University’s 2018-19 community report. Report ]

October 2019

SAGE-WHO 2019. Marc Brisson and Mélanie Drolet were present. Marc Brisson presented ‘Impact of HPV Immunization Strategies in the Context of Supply Constraint’ at the Strategic Advisory Group of Experts (SAGE) Working Group on Human Papillomavirus (HPV) Immunization, held in Geneva, Switzerland, October 8-10, 2019. Meeting Agenda (PDF) ]

October 2019

WORKSHOP AT FIELDS INSTITUTE. JF Laprise took part to the workshop ‘Borders in Public Health and Mathematical Epidemiology’ held October 21-25, 2019, The Fields Institute, Toronto, Canada. Workshop schedule ]

October 2019

SMDM 2019. Dave Martin will present ‘Health and Economic Impact of HPV Testing Compared to Cytology’ at the SMDM’s 41st annual meeting held in Portland, Oregon, USA, October 20-23, 2019. SMDM 2019 ]

October 2019

ID WEEK 2019. Marc Brisson and Mélanie Drolet were present. Marc Brisson presented ‘Understanding the Science Behind Planning for Global Elimination of Cervical Cancer’, ID Week 2019 Conference, Washington, DC, USA, October 2-6, 2019. Program (PDF) ]

Août 2019

PUBLICATION IN CMAJ: ‘Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study’ CMAJ ]

August 2019

PUBLICATION IN BMC MEDICINE: ‘Guidelines for multi-model comparisons of the impact of infectious disease interventions’ Pubmed ]

August 2019

PUBLICATION IN VACCINE: ‘An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool’ Pubmed ]

August 2019

PUBLICATION IN HUMAN VACCINES & IMMUNOTHERAPEUTIC: ‘Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study.’ Pubmed ]

July 2019

PUBLICATION OF A WHITE PAPER for the Single Dose HPV Vaccine Evaluation Consortium: ‘Review of the current published evidence for single-dose HPV vaccination 2nd Edition’ pdf ]

June 2019

WIDESPREAD MEDIA COVERAGE of our article published in The Lancet from local to national to international level (USA, UK, Australia, Spain, France, Norway, Denmark, Sweden, Hungary, Ireland, Argentina, Dominican Republic, Mexico, Kenya, India, Malaysia) [ Media ] Media tracking ]

June 2019

PUBLICATION IN THE LANCET! ‘Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis’ TheLancet ]

June 2019

CIHR FUNDING. Marc Brisson is a co-investigator of 3 newly CIHR funded projects :
1) Elimination of cervical cancer through vaccination and screening in high HPV prevalence settings : a mathematical modeling and cost-effectiveness study (Principal Investigator : Mathieu Maheu-Giroux) [CIHR 1] ;
2) Illiap Paanganik Qaujisarniq: Tailoring Cervical Cancer Screening Services for Inuit Women of Nunavik (Principal Investigator: Paul Brassard) [CIHR 2] ;
3) Is Ontario prepared for the return of measles? (Principal Investigator : Shelly Bolotin) [CIHR 3]

June 2019

Our team’s work was part of the evidence base that informed the ACIP vote on recommendations to extend HPV vaccination to adults over 26 years of age in the US. CDC ]

June 2019

NEW TEAM MEMBERS! Welcome to Léa Drolet Roy and Gabrielle Hudon, research assistants during the summer of 2019.

June 2019

NEW TEAM MEMBERS! Welcome to Aurélie Godbout and Patricia Lamirande, who will undertake their Master degree in Epidemiology next fall.

June 2019

SAGE-WHO WORKING GROUP MEETING. Marc Brisson presented ‘Optimal HPV vaccination strategies to prevent cervical cancer in LMIC: A mathematical modeling analysis’ at the Strategic Advisory Group of Experts (SAGE) Working Group on Human Papillomavirus (HPV) Immunization, held in Menthon St-Bernard, France, June 7, 2019.

March 2019

PUBLICATION IN THE LANCET ONCOLOGY: ‘Global elimination of cervical cancer as a public health problem’ ScienceDirect ]

February 2019

ACIP MEETING. Marc Brisson was presenting at the meeting of the Advisory Committee on Immunization Practices (ACIP): ‘Cost-Effectiveness of extending HPV vaccination above age 26 years in the U.S.’ (Atlanta, February 27) Meeting Agenda ]

December 2018

EUROGIN 2018. Marc Brisson was chair of the session ‘Two vs one dose vaccine schedules: assessing the evidence’ at EUROGIN 2018 and was invited speaker presenting ‘Population-level impact of 1-dose vaccination in Low and Middle Income Countries vs High Income Countries: Model-based analysis’. (Lisbon, December 2-5) EUROGIN 2018 – PROGRAM (PDF) ]

December 2018

EUROGIN 2018. Philippe Lemieux-Mellouki was presenting at EUROGIN 2018: ‘Impact of changes in sexual behavior on past and future trends of HPV infections and related cancers.’ (Lisbon, December 2-5) [ EUROGIN 2018 – PROGRAM (PDF) ]

October 2018

SAGE-WHO MEETING. Élodie Bénard and Dave Martin were present at the meeting of the WHO Strategic Advisory Group of Experts (SAGE) on immunization held October 23-25, 2018, in Geneva.

October 2018

SAGE-WHO MEETING. Marc Brisson presented at the meeting of the WHO Strategic Advisory Group of Experts (SAGE) on immunization held October 23-25, 2018, in Geneva. Results presented at the meeting will be used for WHO recommendations on HPV vaccination at the Global level.

October 2018

IPVC 2018. Mélanie Drolet was presenting at the 32nd International Papillomavirus Conference: ‘Reduced-dose HPV vaccination effectiveness in post-vaccination surveillance studies: using mathematical modeling to quantify the impact of biases.’ (Sydney, October 2-6)

October 2018

IPVC 2018. Marc Brisson was invited speaker at the 32nd International Papillomavirus Conference IPVC: ‘Modeling cervical cancer elimination’. He also presented: ‘The impact of HPV in the US : insights from comparing mathematical model predictions and surveillance data.’ (Sydney, October 2-6)

June 2018

PUBLICATIONS IN VALUE IN HEALTH: ‘Model Comparisons of the Effectiveness and Cost-effectiveness of Vaccination: A Systematic Review of the Literature’ ScienceDirect ]

May 2018

PUBLICATION IN VACCINE: ‘Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs’ ScienceDirect ]

March 2018

Marc Brisson is member of the newly appointed Expert Panel on the Potential Socio-economic Impacts of Antimicrobial Resistance in Canada of the Council of Canadian Academies. The goal of the panel is to assess the impact Antimicrobial Resistance has on Canadians and the health care system. scienceadvice.ca ]

February 2018

PUBLICATION IN THE INTERNATIONAL JOURNAL OF CANCER: ‘Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9-14 year old girls against human papillomavirus’ PubMed ]

October 2017

GRANT. Marc Brisson is one of the principal investigators on a US$ 5 million grant to 8 independent research institutions from Bill & Melinda Gates Foundation: “HPV 1-dose: Accelerating evidence and implementation”. Marc Brisson’s team is one of the Expert Groups forming the HPV One Dose Consortium.

October 2017

EUROGIN 2017. Marc Brisson was chair of the session ‘What have we learnt from population-wide HPV vaccination programs and how can it guide future vaccination policy?’ and was invited speaker presenting ‘Herd immunity effect’. (Amsterdam, October 8-11) [ EUROGIN 2017 ] Program (PDF)  ]

October 2017

EUROGIN 2017. Mélanie Drolet was invited speaker at EUROGIN 2017: ‘Evidence from post-vaccination studies in high-income countries’. (Amsterdam, October 8-11) [ EUROGIN 2017 ] Program (PDF)  ]

October 2017

EUROGIN 2017. Jean-François Laprise was presenting at EUROGIN 2017: ‘Health and economic impact of HPV testing compared to cytology: what is the optimal primary cervical cancer screening strategy for Canada?’ (Amsterdam, October 8-11) [ EUROGIN 2017 ] Program (PDF) ]

September 2017

PUBLICATION IN THE JOURNAL OF INFECTIOUS DISEASES: ‘The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation.’ Oxford Academic ]

August 2017

PUBLICATION IN EPIDEMICS: ‘Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness’ ScienceDirect ]

August 2017

NEW TEAM MEMBER! Welcome to Guillaume Béraud (Postdoctoral Fellow)

May 2017

Marc Brisson was at the World Health Organization’s workshop ‘WHO Blueprint Plan of Action – Designing a vaccine efficacy trial during Public Health Emergencies: Towards the development of guidelines and interactive tools’. The workshop was held 1-2 May 2017 in Annecy, France.

May 2017

Marc Brisson has ranked 1st in the 2017-2018 Research Scholars Junior 2 competition of the ‘Fonds de recherche du Québec – Santé’ (FRQS).

May 2017

Marc Brisson is a principal investigator on a $ 10 million grant for the Canadian Immunization Research Network (CIRN) obtained from the Public Health Agency of Canada (PHAC) and the Canadian Institutes of Health Research (CIHR).

January 2017

PUBLICATION IN THE AMERICAN JOURNAL OF EPIDEMIOLOGY: ‘Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions.’ PubMed ]

January 2017

WHO IVIR-AC MEETING. Marc Brisson participated to the meeting of the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) on ‘Ad-Hoc Expert Consultation on Clinical Trials of Non-Specific Effects of Vaccines’ at Veyrier-du-Lac, France, January 30-31, 2017

January 2017

NEW TEAM MEMBER! Welcome to Karine Larouche (Master Student in Epidemiology)

December 2016

Our team’s research work is cited in ACIP’s recommendations for ‘Use of a 2-Dose Schedule Human Papillomavirus Vaccination’ CDC ]

December 2016

SAGE-WHO MEETING. SAGE issued recommendations regarding introduction of HPV vaccination in low to middle income countries based partly on modeling results presented by Marc Brisson to SAGE in October 2016. WHO ]

November 2016

INTERVIEW IN ‘PLANÈTE F’ MAGAZINE. Marc Brisson is interviewed about vaccinating boys against HPV Planète F ]

November 2016

PUBLICATION IN LANCET PUBLIC HEALTH: ‘Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis’ [ Lancet Pub Health ] Accompanying Comment ]

October 2016

SAGE-WHO MEETING. Marc Brisson presented at the meeting of the WHO Strategic Advisory Group of Experts (SAGE) on immunization held October 18-20, 2016 in Geneva. Results presented at the meeting will be used for WHO recommendations on HPV vaccination at the Global level. [ Meeting Agenda ] Summary Report ]

October 2016

ACIP MEETING. ACIP voted to recommend a 2-dose HPV vaccination schedule in the US for girls and boys, based partly on modeling results presented by Marc Brisson to ACIP last June. CDC ]

October 2016

PUBLICATION IN EMERGING INFECTIOUS DISEASES: ‘Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes’ Free PMC Article ]

October 2016

PUBLICATION IN CMAJ: ‘Effect of HPV on cervical cancer screening in Alberta.’ PubMed ]

September 2016

PUBLICATION IN PLOS ONE: ‘Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review.’ Free PMC Article ]

September 2016

PUBLICATION IN THE LANCET PUBLIC HEALTH: ‘Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models’ The Lancet ]

June 2016

ACIP MEETING. Marc Brisson was presenting at the meeting of the Advisory Committee on Immunization Practices (Atlanta, June 22-23) [ Summary Report ] [ Meeting Agenda (PDF) ]

June 2016

EUROGIN 2016. Marc Brisson was chair of the session ‘The role of modeling and economics’ and was invited speaker at EUROGIN 2016: ‘What can models tell us about reduced dose schedules?’ (Salzburg, June 15-18) [ EUROGIN 2016 ] [ Program (PDF) ]

June 2016

WHO IVIR-AC MEETING. Marc Brisson attended the Immunization and Vaccines Related Implementation Research (IVIR) Advisory Committee (IVIR-AC) of the World Health Organization (WHO) (Geneva, May 30-June 1)

May 2016

PUBLICATION IN THE JOURNAL OF INFECTIOUS DISEASES: ‘Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis.’ J Infectd Dis ]

May 2016

CONGRATULATIONS TO TALIA! Talía Malagón successfully defended her PhD thesis and obtained the grade of Philosophiae Doctor on May 24th, 2016.

May 2016

CONGRATS LÉA! Léa Drolet-Roy was awarded a bronze medal and a $ 1,000 university scholarship for her project VSV-EBOV contre Ebola at the Canada-Wide Science Fair (CWSF) held last May at McGill University, Montreal. Léa is a high school student coached by our team. Collège Saint-Charles Garnier ]

April 2016

Marc Brisson has been appointed full professor at Laval University.

April 2016

CONGRATS LÉA! Léa Drolet-Roy, a high school student coached by our team, was awarded a prize at the ‘Super Expo-sciences Hydro-Québec, Finale Québécoise’ 2016 for her transmission-dynamic modeling project ‘VSV-EBOV contre Ébola’. Léa will be part of the Quebec delegation at the Canada-Wide Science Fair, Montreal May 15-20, 2016. CWSF ]

March 2016

PUBLICATION IN VACCINE: ‘Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada’ PubMed ]

March 2016

PUBLICATION IN THE INTERNATIONAL JOURNAL OF CANCER: ‘Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines’ Int J Cancer ]

February 2016

PUBLICATION IN THE JOURNAL OF INFECTIOUS DISEASES: ‘The Impact and Cost-Effectiveness of 3 doses of 9-Valent Human Papillomavirus (HPV) Vaccine among US Females Previously Vaccinated with 4-Valent HPV Vaccine’ J Infect Dis ]

February 2016

TEACHING AT IMPERIAL COLLEGE. Marc Brisson is giving a Lecture entitled ‘Economic Evaluation: from uncertainty quantification to public health decision making’ (London, February 11, 2016)

February 2016

WHO MEETING. Marc Brisson is participating in the WHO Ad-hoc Consultation on Epidemiological Studies for Non-Specific Effects of Vaccines (Geneva, 16-17 February 2016)

February 2016

RAC 2016 AWARDS. Our proposal ranked “Outstanding” in Compute Canada’s Resource Allocation Competition (RAC) 2016 and we received a 408 core-year allocation on Colosse supercomputer at Laval University, Quebec. Compute Canada ]

January 2016

PUBLICATION IN EMERGING INFECTIOUS DISEASES: ‘Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior’ CDC ]

January 2016

NEW TEAM MEMBER! Welcome to Dave Martin (Research professional)